Rethinking the use of germline CHEK2 mutation as a marker for PARP inhibitor sensitivity

被引：0
|
作者：
Hayman, Thomas J. [1 ]
机构：
[1] Yale Univ, Dept Therapeut Radiol, Sch Med, 15 York St, New Haven, CT 06510 USA
来源：
JNCI CANCER SPECTRUM | 2024年 / 8卷 / 04期
关键词：
METASTATIC BREAST-CANCER; HOMOLOGOUS RECOMBINATION; SYNTHETIC LETHALITY; DEFICIENCY; OLAPARIB;
D O I：
10.1093/jncics/pkae045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] The landscape of somatic genetic alterations in breast cancers from CHEK2 germline mutation carriers
    Kumar, R.
    Pei, X.
    Selenica, P.
    Wen, H. Y.
    Powell, S.
    Robson, M.
    Riaz, N.
    Reis-Filho, J. S.
    Weigelt, B.
    Mandelker, D.
    CANCER RESEARCH, 2019, 79 (04)
  • [22] Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations
    Bella Kaufman
    Yael Laitman
    Jacek Gronwald
    Robert Winqvist
    Arvids Irmejs
    Jan Lubinski
    Katri Pylkäs
    Janis Gardovskis
    Edvins Miklasevics
    Eitan Friedman
    Familial Cancer, 2009, 8 : 473 - 478
  • [23] PRIMARY MEDIASTINAL B-CELL LYMPHOMA WITH A MATERNALLY INHERITED GERMLINE CHEK2 MUTATION
    Self, Chelsea
    Franklin, Anna
    Suttman, Alexandra
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S193 - S194
  • [24] CHEK2 mutation and hereditary breast cancer
    Narod, Steven A.
    Lynch, Henry T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 6 - 7
  • [25] The Landscape of Somatic Genetic Alterations in Breast Cancers from CHEK2 Germline Mutation Carriers
    Mandelker, Diana
    Kumar, Rahul
    Pei, Xin
    Selenica, Pier
    Setton, Jeremy
    Arunachalam, Sasi
    Ceyhan-Birsoy, Ozge
    Brown, David N.
    Norton, Larry
    Robson, Mark E.
    Wen, Hannah Y.
    Powell, Simon
    Riaz, Nadeem
    Weigelt, Britta
    Reis-Filho, Jorge S.
    JNCI CANCER SPECTRUM, 2019, 3 (02)
  • [26] CHEK2 mutation and hereditary breast cancer
    Bogdanova, Natalia
    Feshchenko, Sergei
    Cybulski, Cezary
    Doerk, Thilo
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (19) : E26 - E26
  • [27] Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germline mutation and non-CHEK2 somatic mutation gene signatures
    Ow, Ghim Siong
    Ivshina, Anna V.
    Fuentes, Gloria
    Kuznetsov, Vladimir A.
    CELL CYCLE, 2014, 13 (14) : 2262 - 2280
  • [28] Excess Risk for Contralateral Breast Cancer in CHEK2*1100delC Germline Mutation Carriers
    Annegien Broeks
    Lot de Witte
    Anke Nooijen
    Angelina Huseinovic
    Jan G.M. Klijn
    Flora E. van Leeuwen
    Nicola S. Russell
    Laura J. van't Veer
    Breast Cancer Research and Treatment, 2004, 83 : 91 - 93
  • [29] Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation Carriers
    Borde, Julika
    Ernst, Corinna
    Wappenschmidt, Barbara
    Niederacher, Dieter
    Weber-Lassalle, Konstantin
    Schmidt, Gunnar
    Hauke, Jan
    Quante, Anne S.
    Weber-Lassalle, Nana
    Horvath, Judit
    Pohl-Rescigno, Esther
    Arnold, Norbert
    Rump, Andreas
    Gehrig, Andrea
    Hentschel, Julia
    Faust, Ulrike
    Dutrannoy, Veronique
    Meindl, Alfons
    Kuzyakova, Maria
    Wang-Gohrke, Shan
    Weber, Bernhard H. F.
    Sutter, Christian
    Volk, Alexander E.
    Giannakopoulou, Olga
    Lee, Andrew
    Engel, Christoph
    Schmidt, Marjanka K.
    Antoniou, Antonis C.
    Schmutzler, Rita K.
    Kuchenbaecker, Karoline
    Hahnen, Eric
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (07): : 893 - 899
  • [30] Polyposis With a Mutation in the CHEK2 Tumor Suppressor Gene
    Greenberg, Ian
    Khan, Omar
    DePersia, Allison
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S938 - S938
12345